BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38398853)

  • 1. Efficacy of Butyrate to Inhibit Colonic Cancer Cell Growth Is Cell Type-Specific and Apoptosis-Dependent.
    Oncel S; Safratowich BD; Lindlauf JE; Liu Z; Palmer DG; Briske-Anderson M; Zeng H
    Nutrients; 2024 Feb; 16(4):. PubMed ID: 38398853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior inhibitory efficacy of butyrate over propionate and acetate against human colon cancer cell proliferation via cell cycle arrest and apoptosis: linking dietary fiber to cancer prevention.
    Zeng H; Hamlin SK; Safratowich BD; Cheng WH; Johnson LK
    Nutr Res; 2020 Nov; 83():63-72. PubMed ID: 33017771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells.
    Hu S; Liu L; Chang EB; Wang JY; Raufman JP
    Mol Cancer; 2015 Oct; 14():180. PubMed ID: 26463716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butyrate Inhibits Deoxycholic-Acid-Resistant Colonic Cell Proliferation via Cell Cycle Arrest and Apoptosis: A Potential Pathway Linking Dietary Fiber to Cancer Prevention.
    Zeng H; Safratowich BD; Wang TTY; Hamlin SK; Johnson LK
    Mol Nutr Food Res; 2020 Apr; 64(8):e1901014. PubMed ID: 32003143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro studies on the inhibition of colon cancer by butyrate and carnitine.
    Roy MJ; Dionne S; Marx G; Qureshi I; Sarma D; Levy E; Seidman EG
    Nutrition; 2009; 25(11-12):1193-201. PubMed ID: 19619983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrate Inhibits Cancerous HCT116 Colon Cell Proliferation but to a Lesser Extent in Noncancerous NCM460 Colon Cells.
    Zeng H; Taussig DP; Cheng WH; Johnson LK; Hakkak R
    Nutrients; 2017 Jan; 9(1):. PubMed ID: 28045428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate-mediated acquisition of chemoresistance by human colon cancer cells.
    Kang HR; Choi HG; Jeon CK; Lim SJ; Kim SH
    Oncol Rep; 2016 Aug; 36(2):1119-26. PubMed ID: 27277338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrate and deoxycholic acid play common and distinct roles in HCT116 human colon cell proliferation.
    Zeng H; Claycombe KJ; Reindl KM
    J Nutr Biochem; 2015 Oct; 26(10):1022-8. PubMed ID: 26026836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.
    Chang CC; Kao WY; Liu CY; Su HH; Kan YA; Lin PY; Ku WC; Chang KW; Yang RN; Huang CJ
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35417036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different molecular events account for butyrate-induced apoptosis in two human colon cancer cell lines.
    Avivi-Green C; Polak-Charcon S; Madar Z; Schwartz B
    J Nutr; 2002 Jul; 132(7):1812-8. PubMed ID: 12097652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon.
    Thangaraju M; Cresci GA; Liu K; Ananth S; Gnanaprakasam JP; Browning DD; Mellinger JD; Smith SB; Digby GJ; Lambert NA; Prasad PD; Ganapathy V
    Cancer Res; 2009 Apr; 69(7):2826-32. PubMed ID: 19276343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
    Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
    J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bipartite butyrate-responsive element in the human calretinin (CALB2) promoter acts as a repressor in colon carcinoma cells but not in mesothelioma cells.
    Häner K; Henzi T; Pfefferli M; Künzli E; Salicio V; Schwaller B
    J Cell Biochem; 2010 Feb; 109(3):519-31. PubMed ID: 19998412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrate, a dietary fiber derivative that improves irinotecan effect in colon cancer cells.
    Encarnação JC; Pires AS; Amaral RA; Gonçalves TJ; Laranjo M; Casalta-Lopes JE; Gonçalves AC; Sarmento-Ribeiro AB; Abrantes AM; Botelho MF
    J Nutr Biochem; 2018 Jun; 56():183-192. PubMed ID: 29587241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol enhances the differentiation induced by butyrate in caco-2 colon cancer cells.
    Wolter F; Stein J
    J Nutr; 2002 Jul; 132(7):2082-6. PubMed ID: 12097697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells.
    Archer SY; Meng S; Shei A; Hodin RA
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6791-6. PubMed ID: 9618491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrate-induced apoptosis in HCT116 colorectal cancer cells includes induction of a cell stress response.
    Fung KY; Brierley GV; Henderson S; Hoffmann P; McColl SR; Lockett T; Head R; Cosgrove L
    J Proteome Res; 2011 Apr; 10(4):1860-9. PubMed ID: 21235278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.
    Mariadason JM; Corner GA; Augenlicht LH
    Cancer Res; 2000 Aug; 60(16):4561-72. PubMed ID: 10969808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation.
    Mariadason JM; Velcich A; Wilson AJ; Augenlicht LH; Gibson PR
    Gastroenterology; 2001 Mar; 120(4):889-99. PubMed ID: 11231943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis by the medium-chain length fatty acid lauric acid in colon cancer cells due to induction of oxidative stress.
    Fauser JK; Matthews GM; Cummins AG; Howarth GS
    Chemotherapy; 2013; 59(3):214-24. PubMed ID: 24356281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.